generics

Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Fierce Pharma
Mon, 07/16/18 - 11:29 am
Mylan Labs
Copaxone
generics
Teva Pharmaceuticals
MS
drug pricing
U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
Reuters
Sat, 07/14/18 - 01:31 pm
Jazz Pharmaceuticals
narcolepsy
Xyrem
Amneal
generics
Generic Approvals Rebound as First Generics Don’t Keep Pace With 2016 or 2017
RAPS.org
Mon, 07/9/18 - 06:41 pm
generics
drug approvals
Mylan launches generic drug-delivery patch for dementia patients
Drug Delivery Business News
Mon, 07/9/18 - 11:26 am
Mylan
rivastigmine
generics
Novartis
Exelon
dementia
Alzheimer's disease
Parkinson's Disease
FDA Finalizes Guidance on GDUFA II
RAPS.org
Wed, 07/4/18 - 11:28 am
FDA
generics
GDUFA
Apotex Faces Uncertainty After Founder's Mysterious Death
Topix
Sat, 06/30/18 - 12:10 pm
generics
Apotex
AbbVie, AndroGel partner owe $448 million in antitrust case - U.S. judge
Yahoo/Reuters
Fri, 06/29/18 - 09:26 pm
AbbVie
Androgel
generics
antitrust
Sanofi, Advent finally shake hands on $2.2B European generics sale
Fierce Pharma
Fri, 06/29/18 - 09:42 am
Sanofi
Europe
generics
Advent International
Zentiva
M&A
FDA Updates List of Drugs Without Generic Competition
RAPS.org
Tue, 06/26/18 - 10:11 pm
FDA
generics
patents
U.S. District Court rules in favor of Lilly's Alimta patent
Yahoo/Reuters
Sat, 06/23/18 - 01:01 pm
Eli Lilly
Alimta
Hospira
Dr Reddy's
generics
patents
Gottlieb lays out FDA plans to speed generic reviews, spur label updates
Biopharma Dive
Wed, 06/20/18 - 10:56 am
FDA
Scott Gottlieb
generics
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Fri, 06/15/18 - 09:49 pm
Indivior
FDA
generics
Suboxone Film
opioids
opioid addiction
Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions
NY Shock Exchange
Thu, 06/14/18 - 06:48 pm
Allergan
Restasis
Kroger
Walgreens
generics
A Look at FDA's FY2018 Generic Drug Performance
RAPS.org
Mon, 06/11/18 - 09:50 pm
generics
Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024
Center for Biosimilars
Sat, 06/9/18 - 05:23 pm
biosimilars
patent cliff
generics
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
Sat, 06/9/18 - 10:11 am
AstraZeneca
guidance
generics
Crestor
Japan
Europe
CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect
Fierce Pharma
Wed, 06/6/18 - 11:33 am
drug reps
layoffs
Acorda Therapeutics
AMPYRA
generics
FDA: Generics Approved in 2017 Led to $8.8B in Savings
RAPS.org
Tue, 06/5/18 - 10:49 pm
FDA
generics
drug pricing
drug approvals
EU makes it easier for companies to produce generic medicines for export
Reuters
Mon, 05/28/18 - 01:42 pm
Europe
European Commission
generics
exporting
FDA demonizes pharma over generics, but most company reputations can take the blow
Fierce Pharma
Wed, 05/23/18 - 11:49 am
generics
pharma industry
FDA
reputation

Pages